MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies (L38123) - R2 - Effective March 28, 2024

Date Posted: March 28, 2024

This Local Coverage Determination (LCD) has been revised under contractor numbers: 01111 (CA), 01211 (AS, GU, HI, NMI), 01311 (NV), and 01911 (CA, HI & Territories).

Effective Date: March 28, 2024

Summary of Changes:

Under CMS National Coverage Policy updated section headings. Under Bibliography changes were made to citations to reflect AMA citation guidelines. Formatting, punctuation and typographical errors were corrected throughout the LCD.

Visit the Active LCDs webpage to view the Active LCD or access it via the CMS MCD.

Last Updated Mar 28 , 2024